New update from Natural Medicines (accessible to HEALWA users):
“The FDA is warning consumers about using CBD during pregnancy. While there isn’t any clinical research on CBD use in pregnant and breastfeeding women, the FDA strongly advises against it.
This advisory stems, in part, from the fact that some CBD products have been found to contain significant quantities of THC. THC can affect infant brain development. THC can also stay in breastmilk for up to six days after use and can lead to long-term developmental consequences for a newborn. Both pregnant and breastfeeding women should avoid it.
Another concern is that CBD itself may affect fetal development. Animal research shows that CBD can cause reproductive problems in male fetuses. It’s also expected that CBD is transferred through breast milk just like THC.
The FDA has approved only one CBD product – the prescription drug Epidiolex – for use in rare seizure disorders. This product is standardized to guarantee the removal of contaminants, including THC. Taking any other CBD product puts the mother and child at risk for exposure to unsafe substances. And as with all other CBD products, the safety of Epidiolex in pregnancy is unclear.
Make sure your pregnant and breastfeeding patients understand that taking any cannabis products, including CBD, might put her child at risk for many long-term issues.”